PTIX

Protagenic Therapeutics

PTIX, USA

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

https://phytanix.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PTIX
stock
PTIX

Analysis Recap: Why EEFT stock could be next big winner - Market Performance Report & Safe Entry Point Identification moha.gov.vn

Read more →
PTIX
stock
PTIX

Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) Setenews

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$4

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.39

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Low

11.50 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-40.54 %

Low ≤ 2%

High ≥ 10%

Investors

* Institutions hold a combined 13.50% of the total shares of Protagenic Therapeutics

1.

Virtu Financial LLC

(3.1946%)

since

2025/06/30

2.

Alpine Partners VI, LLC

(2.7772%)

since

2025/06/30

3.

Morgan Stanley - Brokerage Accounts

(2.5481%)

since

2025/06/30

4.

Susquehanna International Group, LLP

(1.725%)

since

2025/06/30

5.

UBS Group AG

(1.5321%)

since

2025/06/30

6.

Fidelity Extended Market Index

(0.5554%)

since

2025/07/31

7.

Vanguard Institutional Extnd Mkt Idx Tr

(0.267%)

since

2025/07/31

8.

Fidelity Nasdaq Composite Index

(0.2133%)

since

2025/07/31

9.

Northern Trust Extended Eq Market Idx

(0.1653%)

since

2025/06/30

10.

Tower Research Capital LLC

(0.1488%)

since

2025/06/30

11.

Fidelity Series Total Market Index

(0.1152%)

since

2025/07/31

12.

Citigroup Inc

(0.0662%)

since

2025/06/30

13.

NT Ext Equity Mkt Idx Fd - NL

(0.0382%)

since

2025/06/30

14.

Spartan Total Market Index Pool G

(0.0369%)

since

2025/07/31

15.

NT Ext Equity Mkt Idx Fd - L

(0.0301%)

since

2025/06/30

16.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0297%)

since

2025/06/30

17.

State St US Extended Mkt Indx NL Cl C

(0.0149%)

since

2025/08/31

18.

Vanguard U.S. Eq Idx ÂŁ Acc

(0.0143%)

since

2025/07/31

19.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0085%)

since

2025/06/30

20.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0072%)

since

2024/12/31

21.

SSgA U.S. Total Market Index Strategy

(0.0062%)

since

2025/03/31

22.

Bank of America Corp

(0.001%)

since

2025/06/30

23.

Fidelity U.S. Equity Index Ins Trust

(0.0007%)

since

2025/07/31

24.

HARBOR INVESTMENT ADVISORY, LLC

(0.0002%)

since

2025/06/30

25.

State Street Corp

(0%)

since

2025/06/30

26.

Vanguard Group Inc

(0%)

since

2025/06/30

27.

Geode Capital Management, LLC

(0%)

since

2025/06/30

28.

Advisor Group Holdings, Inc.

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.4702

EPS Estimate

—

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(1)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(1.5)
Quality
Low Quality Business(1)
Value
Overpriced(1.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.